Resistance anywhere is resistance everywhere
Get Smart About Antibiotics: Friday, November 18, 2011
- Antibiotic resistance is one of the world’s most pressing public health threats.
- Antibiotics are the most important tool we have to combat life-threatening bacterial diseases.
- Increased antibiotic resistance is compromising the effectiveness of antibiotics.
- Patients, healthcare providers, hospital administrators, and policy makers must work together to employ effective strategies for improving appropriate antibiotic use – ultimately saving lives.
Geographic Spread of CREs:
- Originally found in only one U.S. state – now spread to 36
- Becoming an alarming problem worldwide
- NDM-1 gene, originally found in India and Pakistan, has spread to the United States, Canada, Netherlands, United Kingdom, Australia, and beyond
- We’ve seen that antibiotic resistance can travel the globe. Klebsiella pneumoniae carbapenemase (KPC) infections, a type of resistant bacteria known as CRE, were once seen in limited locations in the United States but are now found throughout the country.
- Another type of CRE, caused by New Delhi metallo‐beta‐lactamase (NDM‐1), was initially identified in India, but is now present in several other countries.
- Antibiotics are a shared resource – and becoming a scarce resource.
- Appropriate use of existing antibiotics can limit the spread of antibiotic resistance, preserving antibiotics for the future.
- Antibiotic resistance is not just a problem for the person with the infection. Some resistant bacteria have the potential to spread to others – promoting antibiotic-resistant infections.
- Spread the message that antibiotic resistance is a global problem.
- Support work of the Trans Atlantic Task Force on Antimicrobial Resistance (TATFAR), whose purpose is to identify urgent antibiotic resistance issues that can best be addressed by cooperation between the United States and the European Union. Through TATFAR, the European Union and the United States will collectively focus on the following:
- Promoting appropriate therapeutic use of antibiotics in the medical and veterinary communities;
- Preventing antibiotic‐resistant infections;
- Identifying opportunities to learn from each other and to promote an information exchange; and
- Recommending areas of future European Union and United States collaboration.
- Implement hospital infection-control measures to reduce the spread of multidrug‐resistant strains and reinforce national policies on prudent use of antibiotics, reducing the generation of antibiotic‐resistant bacteria.
- Adhere to WHO’s strong recommendations that governments focus control and prevention efforts in four main areas:
- Surveillance for antimicrobial resistance;
- Rational antibiotic use, including education of healthcare workers and the public in the appropriate use of antibiotics;
- Introduction or enforcement of legislation related to stopping the sale of antibiotics without prescription; and
- Strict adherence to infection prevention and control measures, including safe handwashing measures, particularly in healthcare facilities.
- Develop relevant policies and coordinate international efforts with the support of WHO to combat antimicrobial resistance.